Beta Bionics, Inc. (BBNX)

Beta Bionics experienced significant insider trading activity recently, with executives offloading over 700,000 dollars in net value. These thirty-five transactions involved only sales, occurring after the latest earnings report. Amid a twenty-four percent stock decline over ninety days, leadership members including the CFO and CCO consistently executed planned divestments.
Ticker: BBNX Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Beta Bionics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
MARK HOPMAN Officer Officer
Transaction date
Proposed sale
Price
45.30
Quantity 25,451
Value US$3,044,275
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
172.48
Quantity 92,151 +30.3%
Value US$4,707,165
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
234.92
Quantity 60,301
Value US$3,614,534
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.00
Quantity 1,000 -0.5%
Value US$100,000
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
17.00
Quantity 1,000
Value US$100,000
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.04
Quantity 1,000 -0.2%
Value US$100,000
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 1,000
Value US$100,000
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.90
Quantity 1,000 -0.7%
Value US$100,000
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
22.00
Quantity 1,000 -1.5%
Value US$100,000
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 1,000 -1.5%
Value US$100,000
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.35
Quantity 775 -1.4%
Value US$13,446
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
18.96
Quantity 370 -0.7%
Value US$7,015
2.2
MARK HOPMAN Officer Officer
Transaction date
Proposed sale
Price
18.98
Quantity 2,660
Value US$50,487
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
23.00
Quantity 6,430 -24.7%
Value US$147,890
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
22.04
Quantity 8,942
Value US$197,082
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
20.13
Quantity 30,779 -35.3%
Value US$619,640
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
22.00
Quantity 2,650 -1.5%
Value US$58,300
2.3
MICHAEL MENSINGER Officer Officer
Transaction date
Proposed sale
Price
19.23
Quantity 5,300
Value US$101,919
2.2
MARK HOPMAN Officer Officer
Transaction date
Proposed sale
Price
19.23
Quantity 28,119
Value US$540,728
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
15.52
Quantity 775 -0.9%
Value US$12,028
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
18.46
Quantity 36,870 -29.7%
Value US$680,723
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
18.46
Quantity 36,870 -29.7%
Value US$680,723
2.2
MARK HOPMAN Officer Officer
Transaction date
Proposed sale
Price
19.33
Quantity 40,305
Value US$779,096
2.2
Saint Sean President & CEO Executive Director
Transaction date
Planned sale
Price
20.08
Quantity 5,641 -1.4%
Value US$113,259
2.2
Sean Saint Officer Officer
Transaction date
Proposed sale
Price
20.08
Quantity 5,641
Value US$113,259
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Sale
Price
19.11
Quantity 4,375 -2.4%
Value US$83,620
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
19.11
Quantity 6,675 -4.0%
Value US$127,580
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
19.11
Quantity 5,327 -4.1%
Value US$101,815
2.2
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
19.11
Quantity 16,867 -4.0%
Value US$322,381
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
19.11
Quantity 4,221 -2.4%
Value US$80,676
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 6,675
Value US$129,595
2.3
Steven Jon Russell Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 4,221
Value US$81,951
2.2
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 5,327
Value US$103,424
2.2
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.42
Quantity 16,867
Value US$327,473
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 4,375
Value US$84,941
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.03
Quantity 4,896 -2.9%
Value US$83,381
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
17.03
Quantity 4,896
Value US$83,381
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.05
Quantity 5,104 -3.0%
Value US$87,006
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
17.05
Quantity 5,104
Value US$87,007
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
15.01
Quantity 1,258 -1.0%
Value US$18,880
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 1,406 -5.1%
Value US$21,090
2.2
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
14.97
Quantity 1,258
Value US$18,827
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
13.67
Quantity 1,406
Value US$19,220
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
14.00
Quantity 2,811 -9.3%
Value US$39,354
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
12.31
Quantity 275 -0.2%
Value US$3,385
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
12.45
Quantity 2,811
Value US$34,997
2.2
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
12.31
Quantity 275
Value US$3,385
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Sale
Price
12.61
Quantity 4,378 -2.3%
Value US$55,194
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
12.61
Quantity 4,222 -2.4%
Value US$53,227
2.2
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
12.61
Quantity 16,872 -3.9%
Value US$212,707
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
12.61
Quantity 6,676 -3.9%
Value US$84,165
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
12.61
Quantity 5,329 -3.9%
Value US$67,183
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 4,378
Value US$55,995
2.3
Steven Jon Russell Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 4,222
Value US$53,999
2.2
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 5,329
Value US$68,158
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 6,676
Value US$85,386
2.2
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.79
Quantity 16,872
Value US$215,793
Lezack Adam Non-Executive Director
Transaction date
Planned sale
Price
11.21
Quantity 998 -3.5%
Value US$11,188
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
9.95
Quantity 1,998 -13.1%
Value US$19,880
Lezack Adam Non-Executive Director
Transaction date
Planned sale
Price
9.95
Quantity 1,000 -8.0%
Value US$9,950
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
10.11
Quantity 1,998
Value US$20,200
ADAM LEZACK Director Non-Executive Director
Transaction date
Proposed sale
Price
10.11
Quantity 1,998
Value US$20,200
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
11.57
Quantity 353 -0.3%
Value US$4,084
2.2
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
11.57
Quantity 353
Value US$4,084
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
12.52
Quantity 1,064
Value US$13,321
2.2
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
12.52
Quantity 1,428
Value US$17,879
2.2
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.52
Quantity 3,384
Value US$42,368
2.2
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
12.36
Quantity 3,384 -0.8%
Value US$41,832
2.2
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
12.36
Quantity 1,428 -0.8%
Value US$17,652
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Sale
Price
12.36
Quantity 1,064 -0.6%
Value US$13,153
2.2
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
12.36
Quantity 834 -0.6%
Value US$10,310
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
12.36
Quantity 1,026 -0.6%
Value US$12,683
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
30.10
Quantity 2,200 -2.7%
Value US$66,221
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
30.20
Quantity 600 -0.7%
Value US$18,118
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
29.56
Quantity 7,200 -7.9%
Value US$212,832
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-16 2026-11-16 PrS Proposed sale

Officer

Officer
25,451
45.30
US$3,044,275
25,451 45.30 US$3,044,275
2026-11-13 2026-11-11 PlS Planned sale

Chief Financial Officer

Officer
92,151 +30.3%
172.48
US$4,707,165
92,151 +30.3% 172.48 US$4,707,165
2026-11-12 2026-11-11 PrS Proposed sale

Officer

Officer
60,301
234.92
US$3,614,534
60,301 234.92 US$3,614,534
2026-11-12 2026-11-09 PlS Planned sale

Chief Financial Officer

Officer
1,000 -0.5%
17.00
US$100,000
1,000 -0.5% 17.00 US$100,000
2026-11-09 2026-11-09 PrS Proposed sale

Officer

Officer
1,000
17.00
US$100,000
1,000 17.00 US$100,000
2026-11-09 2026-11-05 PlS Planned sale

Chief Financial Officer

Officer
1,000 -0.2%
17.04
US$100,000
1,000 -0.2% 17.04 US$100,000
2026-11-05 2026-11-05 PrS Proposed sale

Officer

Officer
1,000
17.04
US$100,000
1,000 17.04 US$100,000
2026-11-04 2026-11-02 PlS Planned sale

Chief Commercial Officer

Officer
1,000 -0.7%
16.90
US$100,000
1,000 -0.7% 16.90 US$100,000
2026-10-29 2026-10-27 PlS Planned sale

Chief Product Officer

Officer
1,000 -1.5%
22.00
US$100,000
1,000 -1.5% 22.00 US$100,000
2026-10-28 2026-10-26 PlS Planned sale

Chief Commercial Officer

Officer
1,000 -1.5%
20.00
US$100,000
1,000 -1.5% 20.00 US$100,000
2026-10-16 2026-10-14 PlS Planned sale

Chief Commercial Officer

Officer
775 -1.4%
17.35
US$13,446
775 -1.4% 17.35 US$13,446
2026-10-05 2026-10-01 PlS Planned sale

Chief Commercial Officer

Officer
370 -0.7%
18.96
US$7,015
370 -0.7% 18.96 US$7,015
2026-10-01 2026-10-01 PrS Proposed sale

Officer

Officer
2,660
18.98
US$50,487
2,660 18.98 US$50,487
2026-09-23 2026-09-22 PlS Planned sale Non-Executive Director
6,430 -24.7%
23.00
US$147,890
6,430 -24.7% 23.00 US$147,890
2026-09-22 2026-09-22 PrS Proposed sale

Director

Non-Executive Director
8,942
22.04
US$197,082
8,942 22.04 US$197,082
2026-09-17 2026-09-16 PlS Planned sale

Chief Commercial Officer

Officer
30,779 -35.3%
20.13
US$619,640
30,779 -35.3% 20.13 US$619,640
2026-09-17 2026-09-16 PlS Planned sale

Chief Product Officer

Officer
2,650 -1.5%
22.00
US$58,300
2,650 -1.5% 22.00 US$58,300
2026-09-16 2026-09-16 PrS Proposed sale

Officer

Officer
5,300
19.23
US$101,919
5,300 19.23 US$101,919
2026-09-16 2026-09-16 PrS Proposed sale

Officer

Officer
28,119
19.23
US$540,728
28,119 19.23 US$540,728
2026-09-15 2026-09-14 PlS Planned sale

Chief Commercial Officer

Officer
775 -0.9%
15.52
US$12,028
775 -0.9% 15.52 US$12,028
2026-09-10 2026-09-09 PlS Planned sale

Chief Commercial Officer

Officer
36,870 -29.7%
18.46
US$680,723
36,870 -29.7% 18.46 US$680,723
2026-09-10 2026-09-09 PlS Planned sale

Chief Commercial Officer

Officer
36,870 -29.7%
18.46
US$680,723
36,870 -29.7% 18.46 US$680,723
2026-09-09 2026-09-09 PrS Proposed sale

Officer

Officer
40,305
19.33
US$779,096
40,305 19.33 US$779,096
2026-09-04 2026-09-03 PlS Planned sale

President & CEO

Executive Director
5,641 -1.4%
20.08
US$113,259
5,641 -1.4% 20.08 US$113,259
2026-09-03 2026-09-03 PrS Proposed sale

Officer

Officer
5,641
20.08
US$113,259
5,641 20.08 US$113,259
2026-09-03 2026-09-02 S Sale

Chief Product Officer

Officer
4,375 -2.4%
19.11
US$83,620
4,375 -2.4% 19.11 US$83,620
2026-09-03 2026-09-02 S Sale

Chief Financial Officer

Officer
6,675 -4.0%
19.11
US$127,580
6,675 -4.0% 19.11 US$127,580
2026-09-03 2026-09-02 S Sale

Chief Commercial Officer

Officer
5,327 -4.1%
19.11
US$101,815
5,327 -4.1% 19.11 US$101,815
2026-09-03 2026-09-02 S Sale

President & CEO

Executive Director
16,867 -4.0%
19.11
US$322,381
16,867 -4.0% 19.11 US$322,381
2026-09-03 2026-09-02 S Sale

Chief Medical Officer

Officer
4,221 -2.4%
19.11
US$80,676
4,221 -2.4% 19.11 US$80,676
2026-09-03 2026-09-02 PrS Proposed sale

Officer

Officer
6,675
19.42
US$129,595
6,675 19.42 US$129,595
2026-09-03 2026-09-02 PrS Proposed sale

Officer

Officer
4,221
19.42
US$81,951
4,221 19.42 US$81,951
2026-09-03 2026-09-02 PrS Proposed sale

Officer

Officer
5,327
19.42
US$103,424
5,327 19.42 US$103,424
2026-09-03 2026-09-02 PrS Proposed sale

Officer; Director

Executive Director
16,867
19.42
US$327,473
16,867 19.42 US$327,473
2026-09-03 2026-09-02 PrS Proposed sale

Officer

Officer
4,375
19.42
US$84,941
4,375 19.42 US$84,941
2026-06-30 2026-06-29 PlS Planned sale

Chief Financial Officer

Officer
4,896 -2.9%
17.03
US$83,381
4,896 -2.9% 17.03 US$83,381
2026-06-29 2026-06-29 PrS Proposed sale

Officer

Officer
4,896
17.03
US$83,381
4,896 17.03 US$83,381
2026-06-30 2026-06-26 PlS Planned sale

Chief Financial Officer

Officer
5,104 -3.0%
17.05
US$87,006
5,104 -3.0% 17.05 US$87,006
2026-06-26 2026-06-26 PrS Proposed sale

Officer

Officer
5,104
17.05
US$87,007
5,104 17.05 US$87,007
2026-06-25 2026-06-24 PlS Planned sale

Chief Commercial Officer

Officer
1,258 -1.0%
15.01
US$18,880
1,258 -1.0% 15.01 US$18,880
2026-06-25 2026-06-24 PlS Planned sale Non-Executive Director
1,406 -5.1%
15.00
US$21,090
1,406 -5.1% 15.00 US$21,090
2026-06-24 2026-06-24 PrS Proposed sale

Officer

Officer
1,258
14.97
US$18,827
1,258 14.97 US$18,827
2026-06-24 2026-06-24 PrS Proposed sale

Director

Non-Executive Director
1,406
13.67
US$19,220
1,406 13.67 US$19,220
2026-06-05 2026-06-04 PlS Planned sale Non-Executive Director
2,811 -9.3%
14.00
US$39,354
2,811 -9.3% 14.00 US$39,354
2026-06-05 2026-06-04 PlS Planned sale

Chief Commercial Officer

Officer
275 -0.2%
12.31
US$3,385
275 -0.2% 12.31 US$3,385
2026-06-04 2026-06-04 PrS Proposed sale

Director

Non-Executive Director
2,811
12.45
US$34,997
2,811 12.45 US$34,997
2026-06-04 2026-06-04 PrS Proposed sale

Officer

Officer
275
12.31
US$3,385
275 12.31 US$3,385
2026-06-03 2026-06-02 S Sale

Chief Product Officer

Officer
4,378 -2.3%
12.61
US$55,194
4,378 -2.3% 12.61 US$55,194
2026-06-03 2026-06-02 S Sale

Chief Medical Officer

Officer
4,222 -2.4%
12.61
US$53,227
4,222 -2.4% 12.61 US$53,227
2026-06-03 2026-06-02 S Sale

President & CEO

Executive Director
16,872 -3.9%
12.61
US$212,707
16,872 -3.9% 12.61 US$212,707
2026-06-03 2026-06-02 S Sale

Chief Financial Officer

Officer
6,676 -3.9%
12.61
US$84,165
6,676 -3.9% 12.61 US$84,165
2026-06-03 2026-06-02 S Sale

Chief Commercial Officer

Officer
5,329 -3.9%
12.61
US$67,183
5,329 -3.9% 12.61 US$67,183
2026-06-03 2026-06-02 PrS Proposed sale

Officer

Officer
4,378
12.79
US$55,995
4,378 12.79 US$55,995
2026-06-03 2026-06-02 PrS Proposed sale

Officer

Officer
4,222
12.79
US$53,999
4,222 12.79 US$53,999
2026-06-03 2026-06-02 PrS Proposed sale

Officer

Officer
5,329
12.79
US$68,158
5,329 12.79 US$68,158
2026-06-03 2026-06-02 PrS Proposed sale

Officer

Officer
6,676
12.79
US$85,386
6,676 12.79 US$85,386
2026-06-03 2026-06-02 PrS Proposed sale

Officer; Director

Executive Director
16,872
12.79
US$215,793
16,872 12.79 US$215,793
2026-05-26 2026-05-22 PlS Planned sale Non-Executive Director
998 -3.5%
11.21
US$11,188
998 -3.5% 11.21 US$11,188
2026-05-26 2026-05-21 PlS Planned sale Non-Executive Director
1,998 -13.1%
9.95
US$19,880
1,998 -13.1% 9.95 US$19,880
2026-05-26 2026-05-21 PlS Planned sale Non-Executive Director
1,000 -8.0%
9.95
US$9,950
1,000 -8.0% 9.95 US$9,950
2026-05-21 2026-05-21 PrS Proposed sale

Director

Non-Executive Director
1,998
10.11
US$20,200
1,998 10.11 US$20,200
2026-05-21 2026-05-21 PrS Proposed sale

Director

Non-Executive Director
1,998
10.11
US$20,200
1,998 10.11 US$20,200
2026-03-05 2026-03-04 PlS Planned sale

Chief Commercial Officer

Officer
353 -0.3%
11.57
US$4,084
353 -0.3% 11.57 US$4,084
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
353
11.57
US$4,084
353 11.57 US$4,084
2026-03-04 2026-03-02 PrS Proposed sale

Officer

Officer
1,064
12.52
US$13,321
1,064 12.52 US$13,321
2026-03-04 2026-03-02 PrS Proposed sale

Officer

Officer
1,428
12.52
US$17,879
1,428 12.52 US$17,879
2026-03-04 2026-03-02 PrS Proposed sale

Officer; Director

Executive Director
3,384
12.52
US$42,368
3,384 12.52 US$42,368
2026-03-03 2026-03-02 S Sale

President & CEO

Executive Director
3,384 -0.8%
12.36
US$41,832
3,384 -0.8% 12.36 US$41,832
2026-03-03 2026-03-02 S Sale

Chief Financial Officer

Officer
1,428 -0.8%
12.36
US$17,652
1,428 -0.8% 12.36 US$17,652
2026-03-03 2026-03-02 S Sale

Chief Product Officer

Officer
1,064 -0.6%
12.36
US$13,153
1,064 -0.6% 12.36 US$13,153
2026-03-03 2026-03-02 S Sale

Chief Commercial Officer

Officer
834 -0.6%
12.36
US$10,310
834 -0.6% 12.36 US$10,310
2026-03-03 2026-03-02 S Sale

Chief Medical Officer

Officer
1,026 -0.6%
12.36
US$12,683
1,026 -0.6% 12.36 US$12,683
2026-01-07 2026-01-06 PlS Planned sale

Chief Product Officer

Officer
2,200 -2.7%
30.10
US$66,221
2,200 -2.7% 30.10 US$66,221
2026-01-05 2026-01-02 PlS Planned sale

Chief Product Officer

Officer
600 -0.7%
30.20
US$18,118
600 -0.7% 30.20 US$18,118
2026-01-05 2026-01-02 PlS Planned sale

Chief Product Officer

Officer
7,200 -7.9%
29.56
US$212,832
7,200 -7.9% 29.56 US$212,832

See older Beta Bionics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Beta Bionics, Inc. history with Plus

Billed monthly · Cancel anytime